Pharma, biotech, medical device, and health professionals, will gather at DGE’S 2nd Investigator-Initiated Trial Summit to learn sound tips and strategies that lead to treatment options and important therapies that aid in cancer research. Experts and industry leaders will conduct keynote discussions and fireside chats on topics related to managing costs and securing operational support in investigator-initiated trials.
At the summit, medical professionals learn to identify the challenges and the best selection criteria for evaluating investigators and proposed IITs. Leaders will also discuss the importance of RWE (Real World Evidence) for the development of treatment plans and strategies.
Participants can understand the part played by IIT strategies for investigator trials, and experts will offer solutions for common issues while managing IT programs.
To learn more, please visit https://ibn.fm/D0e94